SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
BIOMARIN PHARMACEUTICAL INC.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
--------------------------------------------------------------------------------
(Title of Class of Securities)
09061G 10 1
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the one pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
/1/ The remainder of this cover page shall be filled out for a reporting
person's initial filing on this with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 (the "Act") or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP NO. 09061G 10 1 13G Page 2 of 17 Pages
-------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S. S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MPM Capital L.P.
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
2,810,787 (1)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY None
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,810,787 (1)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
None
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,810,787 (1)
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
7.65%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
PN
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 09061G 10 1 13G Page 3 of 17 Pages
-------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S. S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BB BioVentures L.P.
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
2,810,787 (1)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY None
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,810,787 (1)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
None
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,810,787 (1)
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
7.65%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
PN
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 09061G 10 1 13G Page 4 of 17 Pages
-------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S. S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BAB BioVentures, LP
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
2,810,787 (1)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY None
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,810,787 (1)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
None
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,810,787 (1)
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
7.65%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
PN
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 09061G 10 1 13G Page 5 of 17 Pages
-------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S. S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MPM BioVentures Parallel Fund, L.P.
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
2,810,787 (1)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY None
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,810,787 (1)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
None
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,810,787 (1)
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
7.65%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
PN
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 09061G 10 1 13G Page 6 of 17 Pages
-------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S. S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BAB BioVentures, N.V.
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Netherlands Antilles
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
2,810,787 (1)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY None
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,810,787 (1)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
None
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,810,787 (1)
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
7.65%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
CO
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 09061G 10 1 13G Page 7 of 17 Pages
-------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S. S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MPM BioVentures I LP
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
2,810,787 (1)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY None
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,810,787 (1)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
None
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,810,787
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
7.65%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
PN
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 09061G 10 1 13G Page 8 of 17 Pages
-------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S. S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MPM BioVentures I LLC
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
2,810,787 (1)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY None
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,810,787 (1)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
None
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,810,787 (1)
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
OO
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 09061G 10 1 13G Page 9 of 17 Pages
-------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S. S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MPM Asset Management LLC
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
2,810,787 (1)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY None
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,810,787 (1)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
None
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,810,787 (1)
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
7.65%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
OO
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 09061G 10 1 13G Page 10 of 17 Pages
-------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S. S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Medical Portfolio Management, LLC
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
2,810,787 (1)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY None
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,810,787 (1)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
None
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,810,787 (1)
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
OO
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 09061G 10 1 13G Page 11 of 17 Pages
-------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S. S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MPM Asset Management Investors 1998 LLC
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
2,810,787 (1)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY None
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 2,810,787 (1)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
None
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
2,810,787 (1)
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
7.65%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
OO
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
STATEMENT ON SCHEDULE 13G
Item 1(a). Name of Issuer:
--------------
BioMarin Pharmaceutical Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
-----------------------------------------------
371 Bel Marin Keys Boulevard, Suite 210, Novato, CA 94949
Item 2(a). Names of Person Filing:
----------------------
MPM Capital L.P.
BB BioVentures L.P.
BAB BioVentures L.P.
MPM BioVentures Parallel Fund, L.P.
BAB BioVentures, N.V.
MPM BioVentures I LP
MPM BioVentures I LLC
MPM Asset Management LLC
Medical Portfolio Management, LLC
MPM Asset Management 1998 LLC
Item 2(b). Business Mailing Address for the Person Filing:
----------------------------------------------
c/o MPM Capital L.P.
One Cambridge Center, 9th Floor
Cambridge, MA 02142
Item 2(c). Citizenship:
-----------
All entities were organized in Delaware, except BAB BioVentures,
N.V., which was formed under the laws of the Netherlands Antilles.
Item 2(d). Title of Class of Securities:
----------------------------
Common Stock
Item 2(e). CUSIP Number:
------------
09061G 10 1
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b),
-------------------------------------------------------------------
check whether the person filing is a:
------------------------------------
Not Applicable
Item 4. Ownership:
---------
(a) Amount Beneficially Owned:
2,810,787 (1)
(b) Percent of Class Owned:
7.65%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
2,810,787 shares of Common Stock (1)
(ii) shared power to vote or to direct the vote:
None
(iii) sole power to dispose or to direct the disposition of:
2,810,787 shares of Common Stock (1)
(iv) shared power to dispose or to direct the disposition of:
None
Item 5. Ownership of Five Percent or Less of a Class:
--------------------------------------------
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
---------------------------------------------------------------
Various persons have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale of, the
shares to which this statement relates. No one person's interest in
such shares is more than five percent of the total outstanding stock
of the Issuer.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
----------------------------------------------------------------------
Security Being Reported on By the Parent Holding Company:
--------------------------------------------------------
Not Applicable
Item 8. Identification and Classification of Members of the Group:
---------------------------------------------------------
Not Applicable
Item 9. Notice of Dissolution of Group:
------------------------------
Not Applicable
Item 10. Certification:
-------------
Not Applicable
(1) Includes shares held through interests in MPM Capital L.P. ("MPM Capital")
and in entities directly or indirectly controlled by it. MPM Capital is a
direct or indirect parent and/or a control person of MPM Asset Management
LLC and funds managed or advised by it, and of the general partners of such
funds. Also includes shares held through interests in Medical Portfolio
Management LLC, the general partner of MPM Capital. Among the shares
included, 2,690,912 shares are held by MPM BioVentures L.P.; 30,083 shares
are held by MPM BioVentures Parallel Fund, L.P.; 4,792 shares are held by
MPM Asset Management Investors 1998 LLC and 85,000 shares are shares
issuable upon the exercise of options held by Ansbert S. Gadicke
exercisable within 60 days of December 31, 2000. Among such shares
issuable upon the exercise of options held by Dr. Gadicke, 30,000 may also
be beneficially owned by BB BioVentures L.P. and MPM BioVentures Parallel
Fund, L.P., and 55,000 may also be beneficially owned by MPM Asset
Management LLC. Each reporting person herein disclaims beneficial
ownership of shares not directly held by such reporting person.
Signature
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 14, 2001
MPM CAPITAL L.P. BB BIOVENTURES L.P.
By: Medical Portfolio Management LLC, By: BAB BioVentures L.P.,
its General Partner its General Partner
By: BAB BioVentures N.V.,
its General Partner
By: /s/ Ansbert S. Gadicke
-----------------------------------
Name: Ansbert S. Gadicke
Title: Manager By: /s/ Ansbert S. Gadicke
----------------------------------
Name: Ansbert S. Gadicke
Title: Manager
BAB BIOVENTURES L.P. MPM BIOVENTURES PARALLEL FUND, L.P.
By: BAB BioVentures, N.V., By: MPM BioVentures I LP,
its General Partner its General Partner
By: /s/ Ansbert S. Gadicke
----------------------------------- By: MPM BioVentures I LLC,
Name: Ansbert S. Gadicke its General Partner
Title: Manager
By: /s/ Ansbert S. Gadicke
----------------------------------
Name: Ansbert S. Gadicke
Title: Manager
BAB BIOVENTURES, N.V. MPM BIOVENTURES I LP
By: MPM BioVentures I LLC,
its General Partner
By: /s/ Ansbert S. Gadicke
-----------------------------------
Name: Ansbert S. Gadicke
Title: Manager By: /s/ Ansbert S. Gadicke
----------------------------------
Name: Ansbert S. Gadicke
Title: Manager
MPM BIOVENTURES I LLC MPM ASSET MANAGEMENT LLC
By: /s/ Ansbert S. Gadicke By: /s/ Ansbert S. Gadicke
----------------------------------- ----------------------------------
Name: Ansbert S. Gadicke Name: Ansbert S. Gadicke
Title: Manager Title: Manager
MEDICAL PORTFOLIO MANAGEMENT, LLC MPM ASSET MANAGEMENT 1998 LLC
By: /s/ Ansbert S. Gadicke
-----------------------------------
Name: Ansbert S. Gadicke By: /s/ Ansbert S. Gadicke
Title: Manager ----------------------------------
Name: Ansbert S. Gadicke
Title: Manager
EXHIBIT A
---------
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of
1934, as amended, the undersigned agree to the joint filing on behalf of each of
them of a statement on Schedule 13G (including amendments thereto) with respect
to the Common Stock of BioMarin Pharmaceutical Inc. and further agree that this
agreement be included as an exhibit to such filing. Each party to the agreement
expressly authorizes each other party to file on its behalf any and all
amendments to such statement. Each party to this agreement agrees that this
joint filing agreement may be signed in counterparts.
In evidence whereof, the undersigned have caused this Agreement to be
executed on their behalf this ___ day of February, 2001
MPM CAPITAL L.P. BB BIOVENTURES L.P.
By: Medical Portfolio Management LLC, By: BAB BioVentures L.P.,
its General Partner its General Partner
By: BAB BioVentures N.V.,
its General Partner
By: /s/ Ansbert S. Gadicke
-----------------------------------
Name: Ansbert S. Gadicke
Title: Manager By: /s/ Ansbert S. Gadicke
----------------------------------
Name: Ansbert S. Gadicke
Title: Manager
BAB BIOVENTURES L.P. MPM BIOVENTURES PARALLEL FUND, L.P.
By: BAB BioVentures, N.V., By: MPM BioVentures I LP,
its General Partner its General Partner
By: /s/ Ansbert S. Gadicke
----------------------------------- By: MPM BioVentures I LLC,
Name: Ansbert S. Gadicke its General Partner
Title: Manager
By: /s/ Ansbert S. Gadicke
----------------------------------
Name: Ansbert S. Gadicke
Title: Manager
BAB BIOVENTURES, N.V. MPM BIOVENTURES I LP
By: MPM BioVentures I LLC,
its General Partner
By: /s/ Ansbert S. Gadicke
-----------------------------------
Name: Ansbert S. Gadicke
Title: Manager By: /s/ Ansbert S. Gadicke
----------------------------------
Name: Ansbert S. Gadicke
Title: Manager
MPM BIOVENTURES I LLC MPM ASSET MANAGEMENT LLC
By: /s/ Ansbert S. Gadicke By: /s/ Ansbert S. Gadicke
----------------------------------- ----------------------------------
Name: Ansbert S. Gadicke Name: Ansbert S. Gadicke
Title: Manager Title: Manager
MEDICAL PORTFOLIO MANAGEMENT, LLC MPM ASSET MANAGEMENT 1998 LLC
By: /s/ Ansbert S. Gadicke
-----------------------------------
Name: Ansbert S. Gadicke By: /s/ Ansbert S. Gadicke
Title: Manager ----------------------------------
Name: Ansbert S. Gadicke
Title: Manager